DNIRA Eye Imaging for Precise AMD and Pseudodrusen Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective treatments and diagnoses of blinding eye diseases such as AMD or RPD, with existing technologies failing to address the challenges of existing technologies failing to address the challenges of existing technologies in effectively treating and diagnosing blinding eye diseases, particularly age-related macular degeneration (AMD) and reticular pseudodrusen (RPD).
Innovation Solution
A method for identifying candidate compounds for treating blinding eye diseases by administering a fluorescent compound and a toxin to an animal's eye, exposing it to light to cause fluorescence, and comparing the fluorescence pattern with a control to select effective compounds, along with administering specific compounds like methotrexate or Formula I to treat AMD and RPD.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional imaging techniques are used to diagnose AMD and RPD, then the diagnostic process is straightforward, but the measurement precision and detection capability are insufficient to distinguish between drusen and pseudodrusen
Solution Approach 1:
The imaging system segments the diagnostic process into multiple wavelength channels (blue, green, red, near-infrared) that can be independently optimized for different tissue depths and structures. This allows precise differentiation of drusen vs. pseudodrusen by analyzing their distinct optical signatures at each wavelength, resolving the contradiction between detection precision and system complexity through functional segmentation.
Solution Approach 2:
The patent adds the dimension of spectral analysis by implementing multi-wavelength imaging capabilities. By capturing images across the electromagnetic spectrum from visible to near-infrared, the system creates a spectral fingerprint for each tissue type, enabling precise differentiation of pathological features that appear similar in conventional single-wavelength imaging.
2Measurement precision
If multi-wavelength imaging is implemented to improve detection precision, then diagnostic accuracy improves, but the device complexity and operational difficulty increase
Solution Approach 1:
The imaging system is designed with universal multi-functionality, where a single device performs diagnostic imaging across multiple wavelengths and provides automated analysis algorithms that interpret the complex multi-spectral data. This integration of multiple functions into one system maintains ease of operation while achieving high detection accuracy through sophisticated but automated multi-wavelength analysis.
Solution Approach 2:
The system incorporates self-service features through automated image processing algorithms that automatically calibrate, analyze, and interpret multi-wavelength images without requiring manual intervention. The software automatically distinguishes between different pathological features based on their spectral characteristics, eliminating the need for operators to manually analyze complex multi-spectral data.
3Reliability
If fluorescent compounds and toxins are administered to animal eyes for compound screening, then the ability to identify effective treatment compounds improves, but the complexity of the screening process increases
Solution Approach 1:
The screening methodology employs preliminary action by pre-administering fluorescent compounds and toxins to animal eyes before exposing them to test compounds. This preparatory step creates a controlled pathological model with visible fluorescent markers, allowing systematic evaluation of compound efficacy through fluorescence pattern analysis, thereby improving screening reliability while maintaining procedural organization.
Solution Approach 2:
The screening system incorporates feedback mechanisms where fluorescence patterns are captured and immediately analyzed to determine compound efficacy. The system provides real-time feedback on whether test compounds successfully inhibit toxin-induced damage, allowing iterative optimization of screening conditions and rapid identification of effective compounds through automated image analysis and comparison algorithms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides a means to identify and treat blinding eye diseases such as AMD and RPD, and the use of analytical methods to detect and measure blinding eye diseases, including the use of delayed near infra-red analysis (DNIRA) to generate models for AMD and RPD.
Implementation Method 1
exposing it to light having a wavelength and intensity effective to cause the fluorescent compound to fluoresce
Data Source
AI summary
This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).